Show simple item record

M2 Macrophages promote IL-33 expression, ILC2 expansion and mucous metaplasia in response to early life rhinovirus infections

dc.contributor.authorHan, M
dc.contributor.authorBreckenridge, HA
dc.contributor.authorKuo, S
dc.contributor.authorSingh, S
dc.contributor.authorGoldsmith, AG
dc.contributor.authorLi, Y
dc.contributor.authorKreger, JE
dc.contributor.authorBentley, JK
dc.contributor.authorHershenson, MB
dc.coverage.spatialSwitzerland
dc.date.accessioned2023-02-01T17:43:13Z
dc.date.available2023-02-01T17:43:13Z
dc.date.issued2022-08-12
dc.identifier.issn1664-3224
dc.identifier.issn1664-3224
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pubmed/36032072
dc.identifier.urihttps://hdl.handle.net/2027.42/175722en
dc.description.abstractWheezing-associated rhinovirus (RV) infections are associated with asthma development. We have shown that infection of immature mice with RV induces type 2 cytokine production and mucous metaplasia which is dependent on IL-33 and type 2 innate lymphoid cells (ILC2s) and intensified by a second heterologous RV infection. We hypothesize that M2a macrophages are required for the exaggerated inflammation and mucous metaplasia in response to heterologous RV infection. Wild-type C57Bl/6J mice and LysMCre IL4Rα KO mice lacking M2a macrophages were treated as follows: (1) sham infection on day 6 of life plus sham on day 13 of life, (2) RV-A1B on day 6 plus sham on day 13, (3) sham on day 6 and RV-A2 on day 13, or (4) RV-A1B on day 6 and RV-A2 on day 13. Lungs were harvested one or seven days after the second infection. Wild-type mice infected with RV-A1B at day 6 showed an increased number of Arg1- and Retnla-expressing lung macrophages, indicative of M2a polarization. Compared to wild-type mice infected with RV on day 6 and 13 of life, the lungs of LysMCre IL4Rα KO mice undergoing heterologous RV infection showed decreased protein abundance of the epithelial-derived innate cytokines IL-33, IL-25 and TSLP, decreased ILC2s, decreased mRNA expression of IL-13 and IL-5, and decreased PAS staining. Finally, mRNA analysis and immunofluorescence microscopy of double-infected LysMCre IL4Rα KO mice showed reduced airway epithelial cell IL-33 expression, and treatment with IL-33 restored the exaggerated muco-inflammatory phenotype. Conclusion: Early-life RV infection alters the macrophage response to subsequent heterologous infection, permitting enhanced IL-33 expression, ILC2 expansion and intensified airway inflammation and mucous metaplasia.
dc.format.mediumElectronic-eCollection
dc.languageeng
dc.publisherFrontiers
dc.relation.haspartARTN 952509
dc.rightsLicence for published version: Creative Commons Attribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectIL-33
dc.subjectILC2
dc.subjectM2 macrophage
dc.subjectRhinovirus
dc.subjectneonate
dc.subjectAnimals
dc.subjectImmunity, Innate
dc.subjectInflammation
dc.subjectInterleukin-33
dc.subjectLymphocytes
dc.subjectMacrophages
dc.subjectMetaplasia
dc.subjectMice
dc.subjectRNA, Messenger
dc.subjectRhinovirus
dc.titleM2 Macrophages promote IL-33 expression, ILC2 expansion and mucous metaplasia in response to early life rhinovirus infections
dc.typeArticle
dc.identifier.pmid36032072
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/175722/2/M2 Macrophages promote IL-33 expression, ILC2 expansion and mucous metaplasia in response to early life rhinovirus infection.pdf
dc.identifier.doi10.3389/fimmu.2022.952509
dc.identifier.doihttps://dx.doi.org/10.7302/6936
dc.identifier.sourceFrontiers in Immunology
dc.description.versionPublished version
dc.date.updated2023-02-01T17:42:53Z
dc.identifier.orcid0000-0001-8865-7979
dc.identifier.volume13
dc.identifier.startpage952509
dc.identifier.name-orcidHan, M
dc.identifier.name-orcidBreckenridge, HA
dc.identifier.name-orcidKuo, S
dc.identifier.name-orcidSingh, S
dc.identifier.name-orcidGoldsmith, AG
dc.identifier.name-orcidLi, Y
dc.identifier.name-orcidKreger, JE
dc.identifier.name-orcidBentley, JK; 0000-0001-8865-7979
dc.identifier.name-orcidHershenson, MB
dc.working.doi10.7302/6936en
dc.owningcollnamePediatrics and Communicable Diseases, Department of


Files in this item

Show simple item record

Licence for published version: Creative Commons Attribution 4.0 International
Except where otherwise noted, this item's license is described as Licence for published version: Creative Commons Attribution 4.0 International

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.